By Eddie Sage, majortrend.tv In seeking answers to why adolescent girls are suffering devastating health damage after being injected with HPV vaccines, SANE Vax, Inc decided to have vials of Gardasil tested in a laboratory. There, they found over a dozen Gardasil vaccine vials to be contaminated with rDNA of the Human Papillomavirus (HPV). The […]
A Glimpse into the Scary World of Vaccine Adjuvants
From the Vaccine Risk Awareness Network Adjuvants are formulated compounds, which when combined with vaccine antigens intensify the body’s immune response. They are used to elicit an early, high and long-lasting immune response. “The chemical nature of adjuvants, their mode of action and their reactions (side effect) are highly variable in terms of how they […]
Aluminum in vaccines may be linked to health risks
Straight.com Canada By Gail Johnson, June 21, 2011 Aluminum used in vaccines may be linked to serious health problems, according to a new study by two UBC researchers. But a medical-health officer with Vancouver Coastal Health says the benefits associated with vaccines outweigh the risks. “Aluminum is well demonstrated as a neurotoxin,” said Chris Shaw, […]
Aluminum in Vaccines: Where are the Safety Studies?
By Catherine J. Frompovich Since the 1930s vaccine makers have been using aluminum as an adjuvant in vaccines. However, from what I’ve been able to gather over years of researching vaccines and vaccinations, there doesn’t seem to be studies determining aluminum safety issues. If such studies exist, I hereby request the U.S. CDC and FDA […]
Autism and Vaccines Researcher for CDC, Indicted for Fraud and Money-Laundering
SafeMinds demands long-overdue independent review of vaccine/autism research for data manipulation and conflicts of interest. Vaccine safety remains questionable. ATLANTA, April 14, 2011 /PRNewswire-USNewswire/ — Poul Thorsen, the principal coordinator of multiple studies funded by the Centers for Disease Control and Prevention (CDC) used to deny a vaccine/autism link was indicted on April 13th on […]
